Currently predicting for Thu, 4 Jun 2026

ACLX Prediction Chart

ACLX Predictions History

Latest community submissions for ACLX.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 28, 2026 $69.89 +2.02% $68.14 X 97.43% 0
Jan 28, 2026 $69.37 +1.26% $68.14 X 98.19% 0
Jan 28, 2026 Bullish $68.14 X 0
Dec 22, 2025 $65.65 +2.65% $65.18 V 99.27% 4
Dec 22, 2025 $65.02 +1.65% $65.18 V 99.75% 6
Dec 22, 2025 Bearish $65.18 X 0
Mar 24, 2025 $70.65 +1.91% $72.48 V 97.48% 1
Mar 24, 2025 $70.16 +1.19% $72.48 V 96.80% 1
Mar 24, 2025 Bullish $72.48 V 1
Skagitqg Skagitqg Merchant
Nov 18, 2024 Bearish $88.22 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ACLX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ARCELLX, INC.
Arcellx
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent Sp...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE